Case number 2020-2144
Pfizer Inc. v. Sanofi-Aventis Deutschland > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 27, 2021 | 9 | ORDER granting [748890-2] [748891-2] [748893-2] the motions. The revised official captions are reflected above. Appeal No. 2020-2144 is withdrawn. Each side shall bear its own costs with respect to Appeal No. 2020-2144. ISSUED AS A MANDATE (as to Appeal No. 2020-2144 only): January 27, 2021. Service as of this date by the Clerk of Court. [751964] [20-1871, 20-2029, 20-2032, 20-2033, 20-2034, 20-2159, 20-2066, 20-2068, 20-2069, 20-2071, 20-2144] [LMS] [Entered: 01/27/2021 08:28 AM] (0) |
| Sep 25, 2020 | 7 | ORDER consolidating appeals 20-2071, 20-2139, and 20-2144. The stays of the briefing schedules are lifted. The opening briefs for each group of appeals are due within 60 days from the filing date of the last-filed Certified List within each group. Service as of this date by the Clerk of Court. [724600] [20-2071, 20-2139, 20-2144] [LMN] [Entered: 09/25/2020 04:22 PM] (0) |
| Sep 25, 2020 | 8 | Note to File: The following cases are consolidated: 20-2071 Lead with 20-2139 and 20-2144 Member Cases. The parties must file all documents in the lead appeal only. [724603] [20-2071, 20-2139, 20-2144] [LMN] [Entered: 09/25/2020 04:32 PM] (0) |
| Sep 10, 2020 | 6 | Certified list for 20-2029, 20-2032, 20-2071, 20-2139, and 20-2144 received. Service: 09/08/2020 by email. [720624] [20-1871, 20-2029, 20-2032, 20-2071, 20-2139, 20-2144] [EKD] [Entered: 09/10/2020 09:15 AM] (0) |
| Aug 14, 2020 | 4 | Note to File: The following cases are consolidated: 20-1871 Lead with 20-2139 and 20-2144 Cross-Appeals. The parties must file all documents in the lead appeal only. [714910] [20-1871, 20-2139, 20-2144] [EKD] [Entered: 08/14/2020 12:17 PM] (0) |
| Aug 14, 2020 | 5 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: In light of the consolidation of 20-2144 with 20-1871 as the lead case, no action will be taken regarding Mylan Pharmaceuticals, Inc.'s Entry of Appearance Doc No. [2] and Certificate of Interest, Doc No. [3]. For future filings, the parties must file all documents in the lead appeal only. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [714913] [EKD] [Entered: 08/14/2020 12:26 PM] (0) |
| Aug 13, 2020 | 2 | Entry of appearance for Douglas H. Carsten; Richard Torczon; Elham F. Steiner; Adam Burrowbridge; Wesley E. Derryberry; Tasha M. Thomas as counsel for Mylan Pharmaceuticals, Inc.. Service: 08/13/2020 by email. [714636] [20-2144] [Richard Torczon] [Entered: 08/13/2020 09:28 AM] (0) |
| Aug 13, 2020 | 3 | Certificate of Interest for Mylan Pharmaceuticals, Inc.. Service: 08/13/2020 by email. [714639] [20-2144] [Richard Torczon] [Entered: 08/13/2020 09:30 AM] (0) |
| Aug 10, 2020 | 1 | Appeal docketed. Received: 08/06/2020. [713624] Certified List due on 09/21/2020. [EKD] [Entered: 08/10/2020 10:37 AM] (0) |
